Susan Berland
Director/Board Member at SENTI BIOSCIENCES, INC.
Net worth: - $ as of 30/04/2024
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Curt Herberts | M | 43 |
Senti Sub I, Inc.
Senti Sub I, Inc. BiotechnologyHealth Technology Senti Biosciences, Inc. develops novel therapeutics. It specializes in thetic biology, gene therapy and cell therapy. The company was founded by Timothy K. Lu, Wilson Wong, James J. Collins and Philip Lee in 2016 and is headquartered in South San Francisco, CA. | 6 years |
Timothy Lu | M | 43 |
Senti Sub I, Inc.
Senti Sub I, Inc. BiotechnologyHealth Technology Senti Biosciences, Inc. develops novel therapeutics. It specializes in thetic biology, gene therapy and cell therapy. The company was founded by Timothy K. Lu, Wilson Wong, James J. Collins and Philip Lee in 2016 and is headquartered in South San Francisco, CA. | 8 years |
Deborah Knobelman | M | 51 |
Senti Sub I, Inc.
Senti Sub I, Inc. BiotechnologyHealth Technology Senti Biosciences, Inc. develops novel therapeutics. It specializes in thetic biology, gene therapy and cell therapy. The company was founded by Timothy K. Lu, Wilson Wong, James J. Collins and Philip Lee in 2016 and is headquartered in South San Francisco, CA. | 3 years |
John Orwin | M | 62 | 6 years | |
Ed Mathers Mathers | M | 64 |
Senti Sub I, Inc.
Senti Sub I, Inc. BiotechnologyHealth Technology Senti Biosciences, Inc. develops novel therapeutics. It specializes in thetic biology, gene therapy and cell therapy. The company was founded by Timothy K. Lu, Wilson Wong, James J. Collins and Philip Lee in 2016 and is headquartered in South San Francisco, CA. | 8 years |
Brenda Cooperstone | M | 59 |
Senti Sub I, Inc.
Senti Sub I, Inc. BiotechnologyHealth Technology Senti Biosciences, Inc. develops novel therapeutics. It specializes in thetic biology, gene therapy and cell therapy. The company was founded by Timothy K. Lu, Wilson Wong, James J. Collins and Philip Lee in 2016 and is headquartered in South San Francisco, CA. | 5 years |
Omid Farokhzad | M | 55 | 2 years | |
James Collins | M | 58 | 2 years | |
David Lacey | M | 71 | 8 years | |
Rick Ruiz | M | - | 6 years | |
Thomas P. Chung | M | - | 2 years | |
Kanya Rajangam | M | 50 | 2 years | |
Alex Kolicich | M | - |
Senti Sub I, Inc.
Senti Sub I, Inc. BiotechnologyHealth Technology Senti Biosciences, Inc. develops novel therapeutics. It specializes in thetic biology, gene therapy and cell therapy. The company was founded by Timothy K. Lu, Wilson Wong, James J. Collins and Philip Lee in 2016 and is headquartered in South San Francisco, CA. | 6 years |
Lee Cooper | M | - |
Senti Sub I, Inc.
Senti Sub I, Inc. BiotechnologyHealth Technology Senti Biosciences, Inc. develops novel therapeutics. It specializes in thetic biology, gene therapy and cell therapy. The company was founded by Timothy K. Lu, Wilson Wong, James J. Collins and Philip Lee in 2016 and is headquartered in South San Francisco, CA. | 4 years |
Ran Geng | M | - |
Senti Sub I, Inc.
Senti Sub I, Inc. BiotechnologyHealth Technology Senti Biosciences, Inc. develops novel therapeutics. It specializes in thetic biology, gene therapy and cell therapy. The company was founded by Timothy K. Lu, Wilson Wong, James J. Collins and Philip Lee in 2016 and is headquartered in South San Francisco, CA. | 3 years |
Martin Fussenegger | M | - |
Senti Sub I, Inc.
Senti Sub I, Inc. BiotechnologyHealth Technology Senti Biosciences, Inc. develops novel therapeutics. It specializes in thetic biology, gene therapy and cell therapy. The company was founded by Timothy K. Lu, Wilson Wong, James J. Collins and Philip Lee in 2016 and is headquartered in South San Francisco, CA. | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Hugh Grant | M | 65 | 20 years | |
Frank AtLee | M | 84 | 10 years | |
Neal Gutterson | M | 69 |
Mendel Biotechnology, Inc.
Mendel Biotechnology, Inc. Miscellaneous Commercial ServicesCommercial Services Mendel Biotechnology, Inc. operates as a plant biotechnology company. It develops genetic and chemical solutions for a range of agricultural markets. The firm offers biofuel feedstocks, yield enhancement, flowering, drought tolerance, freezing tolerance, disease resistance, nutrient use efficiency, and cold germination products. The company was founded in 1997 and is headquartered in Newark, CA. | 12 years |
Philip Lee | M | 43 | 7 years | |
Robert Shapiro | M | 85 | 7 years | |
Ronald Martell | M | 62 | - | |
Hugh Young Rienhoff | M | 71 |
DNA Sciences, Inc.
DNA Sciences, Inc. Medical SpecialtiesHealth Technology Part of AbbVie, Inc., DNA Sciences, Inc. is a private company that develops and produces in vitro diagnostic and research reagent products. The company is based in Fremont, CA. The company was founded by Hugh Young Rienhoff. DNA Sciences was acquired by Genaissance Pharmaceuticals, Inc., part of AbbVie, Inc. from October 07, 2005 on April 01, 2003 for $1.30 million. | 3 years |
Charles Stephen McMillan | M | 77 | 18 years | |
Gary Jacob | M | 77 | 1 years | |
Nicholas Simon | M | 67 | 6 years | |
William Parfet | M | 77 | 16 years | |
Karen Auditore-Hargreaves | M | 71 | 6 years | |
Richard de Schutter | M | 83 | 1 years | |
David Epstein | M | 62 | 1 years | |
Duraiswami Narain | M | 60 | 20 years | |
Shirley Cunningham | F | 63 | 15 years | |
David Urso | M | 60 |
DNA Sciences, Inc.
DNA Sciences, Inc. Medical SpecialtiesHealth Technology Part of AbbVie, Inc., DNA Sciences, Inc. is a private company that develops and produces in vitro diagnostic and research reagent products. The company is based in Fremont, CA. The company was founded by Hugh Young Rienhoff. DNA Sciences was acquired by Genaissance Pharmaceuticals, Inc., part of AbbVie, Inc. from October 07, 2005 on April 01, 2003 for $1.30 million. | 2 years |
Herbert Cross | M | 52 | 4 years | |
Michael C. Snabes | M | 75 | 2 years | |
William M. Ziegler | M | - | - | |
David B. Price | M | 79 | 2 years | |
Dale C. Davies | M | 72 | 23 years | |
David W. Lobdell | M | - | 2 years | |
Barbara H. Wells | M | 68 | 17 years | |
Jay Byrne | M | - | 4 years | |
Michael E. Fromm | M | - | 7 years | |
Edward A. Steiger | M | 71 | 5 years | |
Yoshihiro Toyohara | M | - | 1 years | |
Steven Hardardt | M | - | 3 years | |
Don Maszle | M | - |
Mendel Biotechnology, Inc.
Mendel Biotechnology, Inc. Miscellaneous Commercial ServicesCommercial Services Mendel Biotechnology, Inc. operates as a plant biotechnology company. It develops genetic and chemical solutions for a range of agricultural markets. The firm offers biofuel feedstocks, yield enhancement, flowering, drought tolerance, freezing tolerance, disease resistance, nutrient use efficiency, and cold germination products. The company was founded in 1997 and is headquartered in Newark, CA. | 12 years |
David M. Nothmann | M | 51 | 13 years | |
Rajendra D. Ketkar | M | 70 | 14 years | |
Lisa Harrell | F | - | 3 years | |
Milton Wilkins | M | 76 | 8 years | |
Steven Edward Meyer | M | 45 | 19 years | |
Norman Michael Greenberg | M | 64 | 5 years | |
Gary Lee | M | 47 |
Senti Sub I, Inc.
Senti Sub I, Inc. BiotechnologyHealth Technology Senti Biosciences, Inc. develops novel therapeutics. It specializes in thetic biology, gene therapy and cell therapy. The company was founded by Timothy K. Lu, Wilson Wong, James J. Collins and Philip Lee in 2016 and is headquartered in South San Francisco, CA. | 4 years |
Sherri Brown | M | 63 | 19 years | |
Cameron Hall | M | - | 9 years | |
Robert Reiter | M | - | - | |
Jerry Steiner | M | - | 16 years | |
Steve Bierschenk | M | - | 18 years | |
Carlos Popik | M | - | 5 years | |
Dennis Schemm | M | 58 | 12 years | |
Iris Savage | F | - | 5 years | |
Richard S. Goodman | M | - | 7 years | |
Cheni Kwok | M | 55 | - | |
Teresa E. McCaslin | F | 74 | 3 years | |
Mark Andrew Iserloth | M | 61 | 4 years | |
Linda T. Findlay | F | 75 | - | |
Arthur Lee Campbell | M | 73 | 20 years | |
Anik Bose | M | 62 | 4 years | |
Robert A. Paley | M | 76 | - | |
Stephen R. Stetz | M | - | 35 years | |
Kathryn E. Olson | F | 65 | 2 years | |
Ian R. Miller | M | 73 | 3 years | |
John Murabito | M | 65 | 3 years | |
Thomas G. Lim | M | 54 |
DNA Sciences, Inc.
DNA Sciences, Inc. Medical SpecialtiesHealth Technology Part of AbbVie, Inc., DNA Sciences, Inc. is a private company that develops and produces in vitro diagnostic and research reagent products. The company is based in Fremont, CA. The company was founded by Hugh Young Rienhoff. DNA Sciences was acquired by Genaissance Pharmaceuticals, Inc., part of AbbVie, Inc. from October 07, 2005 on April 01, 2003 for $1.30 million. | 2 years |
Cheryl Morley | F | 69 | 12 years | |
Bruce P. Bickner | M | 81 | 3 years | |
Joan H. Walker | F | - | - | |
Arnold Donald | M | 69 | 23 years | |
Gary Crittenden | M | 70 | 2 years | |
Ganesh Kishore | M | 70 | 20 years | |
Judith Reinsdorf | F | 60 | 5 years | |
Amy Yoder | F | 56 | 6 years | |
James Neal | M | 68 | 2 years | |
Hartoun Hartounian | M | 62 | 3 years | |
Pierre Hochuli | M | 77 | 23 years | |
Lee B. Perry | M | 73 |
DNA Sciences, Inc.
DNA Sciences, Inc. Medical SpecialtiesHealth Technology Part of AbbVie, Inc., DNA Sciences, Inc. is a private company that develops and produces in vitro diagnostic and research reagent products. The company is based in Fremont, CA. The company was founded by Hugh Young Rienhoff. DNA Sciences was acquired by Genaissance Pharmaceuticals, Inc., part of AbbVie, Inc. from October 07, 2005 on April 01, 2003 for $1.30 million. | 3 years |
Eric Fencl | M | 61 | 1 years | |
Patrick J. Fortune | M | 77 | 4 years | |
Caroline Loewy | F | 58 | 2 years | |
David A. Karlin | M | 80 | 3 years | |
Mark Tomkins | M | 68 | 6 years | |
Andrew Last | M | 64 | 12 years | |
Atul Dhir | M | - | 2 years | |
Barbara L. Blackford | F | 67 | 3 years | |
Juanita H. Hinshaw | F | 79 | - | |
Gary M. Banks | M | 73 | 6 years | |
Robert G. Potter | M | 84 | 11 years | |
John Hunter | M | 77 | 5 years | |
Kevin P. Buchanan | M | 68 | 10 years | |
Cyndy Donato | M | - | 14 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Susan Berland
- Personal Network